Scientists create genetic ‘pen’ that corrects common heart conditions
By Manuel Ansede,
El País
| 01. 15. 2023
The gene editing techniques that have revolutionized medicine since 2016 could also be used to treat common heart diseases, the number one cause of death in humans, according to a study published recently by one of the world’s leading scientists, Eric Olson, from the US. His team was able to modify two letters – or bases – of the approximately 3 billion that make up the DNA of a mouse. This change was enough to silence a protein linked to multiple cardiovascular problems. Olson is cautious, but highlights the potential advantages of this new strategy: since heart cells last a lifetime, it is only a matter of making the change once.
DNA is like a recipe book for making proteins, the minuscule machines that take care of the main tasks in a living being: carrying oxygen through the blood, fighting viruses, digesting food. That manual is written with four letters, repeated millions of times: ATGGCGAGTTGC… each of these letters is the initial of a chemical compound with different amounts of carbon, hydrogen, nitrogen and oxygen: adenine (C₅H₅N₅), cytosine (C₄H₅N₃O)...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Rob Stein, NPR | 04.23.2026
The Food and Drug Administration approved the first gene therapy to restore hearing for people who were born deaf.
The decision, while only immediately affecting people born with a very rare form of genetic deafness, is being hailed as...
By Emily Mullin, Wired | 04.23.2026
A STARTUP OUT of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually help men with certain types of infertility have biological children...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...